Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
AEMD > SEC Filings for AEMD > Form 8-K on 5-Mar-2014All Recent SEC Filings

Show all filings for AETHLON MEDICAL INC

Form 8-K for AETHLON MEDICAL INC


5-Mar-2014

Other Events


ITEM 8.01 Other Events

On March 5, 2014, Registrant disseminated the Press Release attached to this Current Report as Exhibit 99.1, which announced, among other things, that researchers at Registrant's majority owned subsidiary, Exosome Sciences, Inc. ("ESI") have successfully isolated brain-specific biomarkers associated with a variety of neurodegenerative disorders. The Registrant believes that these discoveries could have implications in the diagnosis, monitoring and treatment of Alzheimer's Disease (AD), Chronic Traumatic Encephalopathy (CTE) and Traumatic Brain Injury (TBI).

The foregoing description of the Press Release does not purport to be complete and is qualified in its entirety by the Press Release attached as Exhibit 99.1 hereto. Readers should review the Press Release for a complete understanding of its content and the matters announced and described in the Press Release.

  Add AEMD to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for AEMD - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.